Sucraid
Sucraid (sacrosidase) Oral Solution:
Approved
Approval ID
d613bb7f-c3f4-462e-81a2-da2347cc4b6b
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Dec 15, 2023
Manufacturers
FDA
QOL Medical, LLC
DUNS: 140026258
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
sacrosidase
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code67871-111
Application NumberBLA020772
Product Classification
M
Marketing Category
C73585
G
Generic Name
sacrosidase
Product Specifications
Route of AdministrationORAL
Effective DateDecember 15, 2023
FDA Product Classification
INGREDIENTS (5)
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
SACROSIDASEActive
Quantity: 8500 [iU] in 1 mL
Code: 8A7F670F2Y
Classification: ACTIB
WATERInactive
Code: 059QF0KO0R
Classification: IACT
ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSL
Classification: IACT
GLYCERINInactive
Code: PDC6A3C0OX
Classification: IACT